Bio-Rad Releases Nineteen Specialized Infrared Spectral Data Collections
News Feb 01, 2006
Bio-Rad Laboratories, Inc. has announced the release of nineteen high-quality infrared databases including: Alcohols and Phenols, Aldehydes, Amino Acids and Peptides, Anhydrides and Lactones, Carboxylic Acids, Dyes, Alkynes, and Azo Compounds, Esters, Explosive Materials, HAZMAT, Hydrocarbons and Halogenated Hydrocarbons, Hydrocarbons, Ketones, Nucleic Acids, Nucelosides, and Nucleotides, Organometallics, Inorganics, Silanes, Boranes, and Deuterium Compounds, Phosphorus Compounds, Polymeric Compounds, Steroids, Sugars and Carbohydrates, Sulfur Compounds.
With the addition of these databases, Bio-Rad now offers over 95 standalone IR spectral databases.
Bio-Rad's spectral databases are used by scientists worldwide in the verification, classification, identification of chemical substances across multiple areas of research, such as pharmaceutical, forensic, environmental, materials sciences, and polymers.
Marie Scandone, Database Product Manager, Bio-Rad Informatics commented, "We have carefully designed these new collections by focusing on specific chemical classes of compounds."
"In doing so, researchers now have an even wider selection of libraries from which to choose those that are most relevant to their studies."
"New collections also of note are the Explosive Materials and HAZMAT databases. Both databases could be used by researchers to identify potentially hazardous and dangerous substances."
"With the release of these databases, Bio-Rad continues their long-standing commitment in providing high-quality, comprehensive spectral data collections to the scientific community," said Ms. Scandone.
Modified Form of Botox Could Replace Opioids as Treatment for Chronic PainNews
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to new research.READ MORE
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein TargetNews
A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers. The new molecule successfully targets a protein that plays a major role in the growth of most cancers.READ MORE